return2ozma@lemmy.world to News@lemmy.world · 6 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square160fedilinkarrow-up1620arrow-down117cross-posted to: [email protected][email protected]
arrow-up1603arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 6 months agomessage-square160fedilinkcross-posted to: [email protected][email protected]
minus-squareMarcbmann@lemmy.worldlinkfedilinkarrow-up2·edit-26 months agoNovo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.
Novo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.